Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

New trial data for Keytruda in triple-negative breast cancer

Keytruda plus chemotherapy showed significant and meaningful improvement

- PMLiVE

Positive results for GSK/CureVac’s COVID-19 vaccine

Vaccine candidate generated strong immune responses in preclinical testing

How to Simplify Genetics & Raise Awareness Around Orphan Diseases

Dr. Gail Ouellette, President and Scientific Director of Regroupement Québécois des Maladies Orphelines (RQMO)/Quebec Coalition of Orphan Diseases and Creator of the “Genetics Simply" website, shares her thoughts on the...

Impetus Digital

Exploring Digital Health From a Patient Perspective

Tjaša Zajc, MedsClub Community Developer and Communication Specialist at Better and the Founder & Host of the Faces of Digital Health podcast, explores international differences in the speed of digital...

Impetus Digital

- PMLiVE

Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments

Continued need for vaccines/treatments 'likely' as world moves into the next phase of the pandemic

- PMLiVE

Pfizer asks UK’s MHRA to approve its COVID-19 vaccine in adolescents

The vaccine has been authorised in the US for 12- to 15-year-olds

- PMLiVE

Clark Health promotes Siân Hurst to managing director role

Hurst initially joined the agency with over 20 years of experience in healthcare communications

- PMLiVE

ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires

Louise Farmer and Jaber Mohamed appointed as directors at strategic communications agency

- PMLiVE

EMA introduces new measures to enable flexibility for non-COVID-19 procedures

Regulator will streamline processes to allow its experts to focus on COVID-19-related assessments

- PMLiVE

Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’

Company says removing IP protections would make it ‘harder’ to make vaccines in the short term

- PMLiVE

New court filing alleges Sanofi destroyed emails relating to Zantac recall

Drugmaker began recalling heartburn drug in 2019 after link to probable human carcinogen

- PMLiVE

Strategic launch planning: familiar framework, new mindset

By James Aird

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links